Healthy Volunteers Clinical Trial
Official title:
Effect of Metabolic State on Anxiety in Human Subjects
In this study, we would like to explore the hypothesis that changes in metabolic state, induced by altering hormone levels and patterns of neural activity, affect the experience of anxiety in humans. We will also investigate if there is a link between high anxiety and higher caloric intake. Our aim is to characterize whether changes in current metabolic state systematically influence anxiety induced by a well established behavioral task known as the threat of shock. The neural regions activated by this behavioral task in healthy subjects have been well characterized. We have a priori regions of interest that include the insula, anterior cingulate cortex, hypothalamus, amygdala, and prefrontal cortex. As our primary outcome, we will assess neural activation with whole-brain functional magnetic resonance imaging to determine whether brain regions are differentially engaged when subjects experience anxiety across different metabolic states. We will correlate these changes with psychophysiological measures of anxiety and metabolic state.
There is evidence that our subjective experience of the world is strongly influenced by our
metabolic state, the status of our body's energy reserves and level of hunger. Hormones that
regulate appetite, food ingestion and body weight apparently also exert their action on
neuroanatomical circuits involved in the generation of psychological states. Previous
research indicates that an individual's metabolic state may influence their susceptibility
to and experience of anxiety. Conversely, stress can also modulate appetite and body weight
regulation. There are many clinical implications of the bidirectional relationship between
stress/anxiety and metabolic state/energy regulation but two of the most important ones are
obesity and eating disorders. In terms of obesity, the high recidivism after successful
weight loss underscores the limited use of caloric restriction to treat obesity. It is
unknown whether dieting (fasting) increases anxiety, which eventually may undermine an
individual's motivation to restrict food intake. Research shows that anxiety can increase
appetite and exacerbate the physical and psychological manifestations associated with
hunger. However, there is a paucity of experimental data establishing whether the metabolic
changes associated with fasting influence the experience of stress and possibly, an
individual's ability to continue dieting for an extended period of time. In the setting of
both obesity and anorexia nervosa, the levels of metabolic hormones are different to those
found in people of normal body weight. It is therefore likely that the activation of brain
regions associated with energy and body weight regulation is abnormal. Many of these brain
regions are also involved in the control of anxiety responses. The fact that there is a high
comorbidity between anorexia nervosa and anxiety disorders indicates the potential
contribution of metabolic states to the perception of stress.
To better understand the relationship between metabolic state and anxiety, we will examine
whether changes in metabolic state influence anxiety in human subjects. We will use
whole-brain functional magnetic resonance imaging (fMRI) to identify the neural mechanisms
that underlie metabolic state-dependent changes in the response to anxiety-inducing stress.
In a randomized crossover design, participants will be tested in a well-established
behavioral task that elicits anticipatory anxiety in two separate sessions that differ with
respect to their metabolic states. We aim to perform a fine-grain analysis of changes in
neural and physiological responses to this anxiety-inducing task as a function of metabolic
state. Using fMRI as well as non-invasive psychophysiological measures, we will characterize
whether there are systematic differences in the neural and psychophysiological experience of
anxiety across different metabolic states in obese as compared to lean individuals.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |